Lv31
260 积分 2021-03-29 加入
Bladder-Preserving Trimodality Therapy With Capecitabine
2小时前
已关闭
Efficacy and safety of dose‐dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle‐invasive bladder cancer
2小时前
已完结
Bladder-Preserving Trimodality Therapy With Capecitabine
2小时前
已关闭
Reply to W. Hryniuk et al
2小时前
已完结
Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial
9天前
已关闭
Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer
9天前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
1个月前
已完结
The evolution of the obesity drug market
6个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
6个月前
已完结
The molecular blueprint of targeted radionuclide therapy
6个月前
已完结
皖公网安备34019202002308
